Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on International Tech Times.
Press releases published on April 2, 2025

DebitMyData Launches Digital Identity LLM-Driven by Agentic Avatar System – Your Data Earns While You Sleep
FORT LAUDERDALE, Fla., April 02, 2025 (GLOBE NEWSWIRE) -- DebitMyData disrupts the digital economy with its proprietary LLM platform, enabling users to earn passive income from their data while combating AI-driven job displacement and DeepFakes. The beta …

Atsena Therapeutics Announces Oversubscribed $150 Million Series C Financing to Further Advance Ocular Gene Therapy Programs
Financing led by new investor Bain Capital with participation from new investor Wellington Management and all existing investors Proceeds to support advancement of ATSN-201 through potential approval and launch as well as preclinical programs to treat …

Quoin Pharmaceuticals Announces Additional Positive ‘Whole Body’ Clinical Data from Ongoing Pediatric Netherton Syndrome Study and Approval to Initiate Testing of a Second Pediatric Patient
Continued Clear Visual Evidence of Almost Completely Healed Skin After 6 weeks Treatment High Durability of Treatment Effect of QRX003 with Continuous Daily Dosing Patient Continues Not to Require Previously Necessary Medications With Patient’s Pruritus …

ProMOS Adopts Silvaco Victory TCAD Solution for the Development of Next-Gen Silicon Photonics Devices
SANTA CLARA, Calif., April 02, 2025 (GLOBE NEWSWIRE) -- Silvaco Group, Inc. (Nasdaq: SVCO) (“Silvaco” or the “Company”), a provider of TCAD, EDA software and SIP solutions that enable semiconductor design and digital twin modeling through AI software and …

Biogen’s Investigational Tau-Targeting Therapy BIIB080 Receives FDA Fast Track Designation for the Treatment of Alzheimer’s Disease
CAMBRIDGE, Mass., April 02, 2025 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to BIIB080, an investigational antisense oligonucleotide (ASO) therapy …

XOMA Royalty to Present at Jones Healthcare and Technology Innovation Conference
EMERYVILLE, Calif., April 02, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (“XOMA”; NASDAQ: XOMA), the biotech royalty aggregator, announced today Chief Investment Officer, Brad Sitko, will be a featured presenter at the Jones Healthcare and …

Sensei Biotherapeutics to Participate in the Canaccord Genuity Horizons in Oncology Virtual Conference
BOSTON, April 02, 2025 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage biotechnology company focused on the discovery and development of next-generation therapeutics for cancer patients, today announced that John Celebi, …

Pyxis Oncology to Participate in the Stifel 2025 Virtual Targeted Oncology Forum
BOSTON, April 02, 2025 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company developing next-generation therapeutics for difficult-to-treat cancers, today announced that Lara S. Sullivan, M.D., President, Chief Executive Officer …

American Tungsten Corp. Joins The Critical Mineral Institute
Vancouver, BC, April 02, 2025 (GLOBE NEWSWIRE) -- American Tungsten Corp. (CSE:TUNG) (OTCQB:DEMRF) (FSE:RK9) (“American Tungsten” or the “Company”) is pleased to announce that it has become a member of the Critical Minerals Institute (the “CMI”). The CMI …

Grove AI Welcomes Former Novartis, UCB, and Google Executives to Company Advisory Board
SAN FRANCISCO, April 02, 2025 (GLOBE NEWSWIRE) -- Grove AI, pioneer in life science automation using agentic AI, today announced the formation of its inaugural Advisory Board. Comprised of prominent leaders from pharmaceutical and technology sectors, the …

Bathroom Vanities Market Size to Reach US$ 52.90 Billion by 2031: In-Depth Research Report by The Insight Partners
US …

Vital Signs Monitoring Devices Market Set to Reach USD 66.82 Billion by 2030, Growing at a CAGR of 12.7% - Exclusive Report by The Insight Partners
US …

Moringa: Learn Why These Moringa Powder Supplements Are Transforming Energy, Immunity, and Overall Health
LAS VEGAS, April 02, 2025 (GLOBE NEWSWIRE) -- Moringa Oleifera, often called the “Miracle Tree,” is rapidly gaining recognition in the U.S. as a superfood for its remarkable health benefits. From boosting daily energy levels to fortifying immune support, …

Cartesian Therapeutics Announces New Employment Inducement Grants
FREDERICK, Md., April 02, 2025 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering cell therapies for the treatment of autoimmune diseases, today announced the granting of …

Syntiant to Unveil Vision Transformer Security Solution at ISC West 2025
IRVINE, Calif., April 02, 2025 (GLOBE NEWSWIRE) -- Syntiant Corp., the recognized leader in low-power edge AI deployment, today announced it will demonstrate its multimodal vision transformer (ViT) at ISC West 2025 in Las Vegas, April 2-4. Deployed on an …

Building on Past Success, Incident IQ Names Ryan Zeek as Chief Financial Officer
ATLANTA, April 02, 2025 (GLOBE NEWSWIRE) -- Incident IQ, the leading workflow management platform built specifically to streamline K-12 school districts, has announced the appointment of Ryan Zeek as Chief Financial Officer. Ryan steps into the role after …

SchoolAI Secures $25 Million to Help Teachers and Schools Reach Every Student
LEHI, Utah, April 02, 2025 (GLOBE NEWSWIRE) -- SchoolAI, a leading AI platform for teaching and learning, today announced it has closed $25 million in Series A funding to tackle education’s fundamental challenge: helping teachers provide personalized …

The NHL and Rogers Announce Monumental 12-Year National Media Rights Deal
Renews highly coveted and valuable hockey rights long term Will deliver more national games and fewer blackouts to hockey fans Rogers is proud to remain the home of NHL hockey TORONTO, April 02, 2025 (GLOBE NEWSWIRE) -- Rogers Communications and the …

La LNH et Rogers annoncent un accord monumental de 12 ans pour les droits de diffusion nationaux
Ces droits très convoités et d’une grande valeur sont renouvelés à long terme L’accord promet aux fans de hockey plus de matchs nationaux et moins de rencontres frappées par des interdictions de diffusion Rogers est fière de demeurer la destination …

Antag Therapeutics initiates Phase 1a trial of AT-7687, a first-in-class GIPR antagonist designed to address key gaps in obesity treatment
Antag Therapeutics initiates Phase 1a trial of AT-7687, a first-in-class GIPR antagonist designed to address key gaps in obesity treatment First subjects dosed in double-blind, placebo-controlled trial assessing AT-7687’s safety, tolerability, …